GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dian Diagnostics Group Co Ltd (SZSE:300244) » Definitions » Research & Development

Dian Diagnostics Group Co (SZSE:300244) Research & Development : ¥337 Mil (TTM As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Dian Diagnostics Group Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Dian Diagnostics Group Co's Research & Development for the three months ended in Sep. 2024 was ¥71 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was ¥337 Mil.


Dian Diagnostics Group Co Research & Development Historical Data

The historical data trend for Dian Diagnostics Group Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dian Diagnostics Group Co Research & Development Chart

Dian Diagnostics Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 211.91 319.10 424.75 638.47 432.64

Dian Diagnostics Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 102.67 112.16 72.33 82.42 70.52

Dian Diagnostics Group Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥337 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dian Diagnostics Group Co  (SZSE:300244) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Dian Diagnostics Group Co Research & Development Related Terms

Thank you for viewing the detailed overview of Dian Diagnostics Group Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Dian Diagnostics Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 329, Jinpeng Street, 5th Floor, Building 2, Xihu District, Zhejiang, Hangzhou, CHN, 310030
Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.
Executives
Tao Jun Securities Affairs Representative
Chen Hai Bin Director
Chen Shi Shi Supervisors
Guo San Hui Executives
Yao Shu Lie Executives
Xu Min Director
Wang Yan Xiao Directors, executives
Chen Zuo Xiu Directors, executives
Hu Yong Director
Hu Miao Shen Executives
Chen Xue Dong Director
Jiang Tang Directors, executives
Wu Zheng Xin Executives
Cheng Xiu Li Supervisors

Dian Diagnostics Group Co Headlines

No Headlines